Benzinga

Benzinga

Benzinga

jueves, septiembre 10

Hims & Hers Health Inc

HIMSNYSE
Trade with Public
Trade with Public
$27.90
-0.27-0.96%
al cierre: Sep 9, 5:00 PM EST
$27.83
-0.07-0.25%
After hour: 7:59 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Hims & Hers Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Hims & Hers Health (HIMS).

Price Target Range — 10 Quarters

Analyst Consensus — 14 Analysts

4Buy
10Hold
Consensus RatingHold# Analysts14Avg. Consensus PT$31Upside to Avg. PT+11.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 24, 2026Truist SecuritiesJailendra SinghPT RaiseHold$27→$32
Aug 21, 2026BarclaysGlen SantangeloPT CutOverweight$39→$35
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $32

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $27 to $32.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight and lowers the price target from $39 to $35.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33

Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $35 to $33.
Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.
Benzinga Newsdesk

PRO
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $30 to $32.
Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved